Published Healthcare & Pharmaceuticals Novel antibiotics We have developed lead BPL antagonist BPL199, which is active against Staphylococcus aureus BPL and Mycobacterium tuberculosis with > 44m-fold less selectivity for human BPL. By University of Adelaide
Published Medical Novel antibiotics Compared to original gA, these gA mutants are highly potent against bacteria but more water-soluble, less-toxic to mammalian cells. By Boston College
Do you have an innovative technology, product or service? Add your solution to the world’s most advanced open innovation platform and get seen by global corporations seeking new solutions – all free of charge.
Published Development of MurJ and FtsW inhibitors to treat antimicrobial resistance Method based on fluorescence anisotropy to measure MurJ and FtsW activities By Yasmina ZEROUAL, University of Liège
Published Multi-application and transversal skills A reality reactive to changes By Monica Saccani, Next Ingredients srl
Share your thoughts, insights and tips Join thousands of like-minded individuals from across the globe to share your insight on fresh innovative topics by posting articles.
